Lec. Dr. Mirna Kifah Faeq

Full Name: Mirna Kifah Faiq

University Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Academic Qualifications: PhD in Clinical Pharmacy

University

Department (Date of Obtaining): University of Baghdad / College of Pharmacy / Clinical Pharmacy Department. Date of Obtaining: September 25, 2023.

Academic Experience:

I hold a PhD in Clinical Pharmacy from the University of Baghdad, College of Pharmacy, 2023.

I am a lecturer at the College of Pharmacy at the University of Tikrit (formerly Tikrit, currently Kirkuk).

I teach courses such as Principles of Pharmacy, Clinical Pharmacy, and Pharmacokinetics, in addition to contributing to summer training for College of Pharmacy students.

A clinical pharmacologist, I have contributed to several scientific papers in peer-reviewed journals.

I have also participated in scientific conferences in medicine and pharmacology, as well as workshops, where I presented research and workshops related to clinical pharmacology.

I am also a member of scientific, examination, and advisory committees.

I am also a scientific reviewer for several peer-reviewed journals included in the Scopus database.

University Information

Faculty: Pharmacy

Department: Pharmacology and Toxicology

Academic Title: Lecturer

Degree: Doctorate

General Specialization: Pharmaceutical Sciences

Subspecialization: Clinical Pharmacy

Academic Activities:

Teaching, conducting research, holding seminars and workshops, and participating in conferences as a contributor and scientific evaluator in both general and specific specializations.

Professor Contact Information:

University Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Published Research:

1-The Belief about Medicines among a Sample of Iraqi Patients with Rheumatoid Arthritis

2-Assessing quality of life among sample of iraqi patients with rheumatoid arthritis

3-Influence of the high mobility group A1 genetic polymorphism on indices of metabolic syndrome and insulin resistance in the Iraqi population: Case-control study

4-Lack of Association of the HMGA1 Gene Variants with Metabolic Syndrome Risk and Response to Oral Anti-Diabetic Drugs

5-High Serum High Mobility Group A1 (HMGA1) Levels are associated with presence of Metabolic Syndrome: Case-control study

6-Lack of association of the HMGA1 gene variants with insulin resistance risk development in the Iraqi population: Case-control study